StockData

Cartesian Therapeutics, Inc. (RNAC) stock

RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.08−0.27 (-4.25%)

Close on Nov 16, 2026Market cap $183.95MP/E –Yield –

Cartesian Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cartesian Therapeutics's total debt was $52.85M at Jun 30, 2026. For fiscal 2025 it was $0.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$52.85M–
Q4 FY2025Dec 31, 2025$0–

More Cartesian Therapeutics figures

See a number that looks wrong?